Skip to main content
. 2022 Jul 6;12:912101. doi: 10.3389/fonc.2022.912101

Figure 4.

Figure 4

High expression of ASF1B indicates poor survival in patients with gliomas. (A) Kaplan–Meier survival curve analysis of overall survival (OS) showed that high ASF1B expression correlated to poor prognosis of gliomas patients from the TCGA database. (B) Kaplan–Meier survival curve analysis of OS showed that high ASF1B expression correlated to poor prognosis of glioma patients from the CGGA database. (C) Time-dependent ROC analysis of ASF1B expression in glioma patients from the TCGA database. (D) Time-dependent ROC analysis of ASF1B expression in glioma patients from the CGGA database. (E) Prognosis of ASF1B expression in subgroups of clinical features from TCGA the database. (F) A nomogram that integrates ASF1B and other prognostic factors in gliomas from the TCGA database. (G) The calibration curve of the nomogram.